Panel recommends approval of new COPD treatment

09/10/2013 | Reuters

An FDA panel voted 11-2 to recommend approval of GlaxoSmithKline's inhaled drug Anoro Ellipta for patients with chronic obstructive pulmonary disease. The drug is a combination of vilanterol and umeclidinium. Some members of the panel cited safety concerns including data that suggest a possible link between the drug and heart problems.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC